Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MJR-35 (dienogest) phase 2 study in functional dysmenorrhea
jRCT2080222925Phase 2
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dienogest in primary dysmenorrhea (PD) (3 arms), sponsored by Mochida Pharmaceutical Co., Ltd.
02
Drugs
dienogest
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on jRCT2080222925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222925.